XXE0X07 |
Measurement of Intracranial Vascular Activity, Computer-aided Assessment, New Technology Group 7 |
XXE0X1A |
Measurement of Intracranial Cerebrospinal Fluid Flow, Computer-aided Triage and Notification, New Technology Group 10 |
XXE0X48 |
Measurement of Brain Electrical Activity, Computer-aided Semiologic Analysis, New Technology Group 8 |
XXE2X19 |
Measurement of Cardiac Output, Computer-aided Assessment, New Technology Group 9 |
XXE3X27 |
Measurement of Pulmonary Artery Flow, Computer-aided Triage and Notification, New Technology Group 7 |
XXE3X58 |
Measurement of Coronary Artery Flow, Quantitative Flow Ratio Analysis, New Technology Group 8 |
XXE3X68 |
Measurement of Coronary Artery Flow, Computer-aided Valve Modeling and Notification, New Technology Group 8 |
XXE5X2A |
Measurement of Infection, Phenotypic Fully Automated Rapid Susceptibility Technology with Controlled Inoculum, New Technology Group 10 |
XXE5X38 |
Measurement of Infection, Whole Blood Reverse Transcription and Quantitative Real-time Polymerase Chain Reaction, New Technology Group 8 |
XXE5X4A |
Measurement of Infection, Positive Blood Culture Small Molecule Sensor Array Technology, New Technology Group 10 |
XXE5XN6 |
Measurement of Infection, Positive Blood Culture Fluorescence Hybridization for Organism Identification, Concentration and Susceptibility, New Technology Group 6 |
XXE5XR7 |
Measurement of Infection, Mechanical Initial Specimen Diversion Technique Using Active Negative Pressure, New Technology Group 7 |
XXE5XT7 |
Measurement of Intracranial Arterial Flow, Whole Blood mRNA, New Technology Group 7 |
XXE5XV7 |
Measurement of Infection, Serum/Plasma Nanoparticle Fluorescence SARS-CoV-2 Antibody Detection, New Technology Group 7 |
XXE5XY9 |
Measurement of Infection, Other Positive Blood/Isolated Colonies Bimodal Phenotypic Susceptibility Technology, New Technology Group 9 |
XXE97U7 |
Measurement of Infection, Nasopharyngeal Fluid SARS-CoV-2 Polymerase Chain Reaction, New Technology Group 7 |
XXEBXQ6 |
Measurement of Infection, Lower Respiratory Fluid Nucleic Acid-base Microbial Detection, New Technology Group 6 |